Although both tumor sites in mice treated with HER2.CART alone showed HER2.CART infiltration 3 days post infusion (Fig. 5b), CART had limited expansion compared to the single tumor model, resulting in no significant tumor control compared to control mice (Supplementary Fig. 10). This evidence concerns the gene CARTPT and neoplasm.